Alkermes plc. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Alkermes plc. (ALKS) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $133.86 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2026-07-28
- 2026-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $133.86M.
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $113.73M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $104.44M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $247.71M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One as first filed |
|---|---|---|
| 2026-06-30 | $133.86M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $113.73M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $104.44M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $247.71M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $283.98M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $278.72M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $324.90M 10-K · filed 2025-02-12 | |
| 2024-09-30 | $313.11M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $244.16M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $223.53M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $207.00M 10-K · filed 2024-02-21 | |
| 2023-09-30 | $214.32M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $165.83M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $272.12M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $318.59M 10-K · filed 2023-02-16 | |
| 2022-09-30 | $318.87M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $326.56M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $247.52M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $177.54M 10-K · filed 2022-02-16 | |
| 2021-09-30 | $178.53M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $194.81M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $238.88M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $242.60M 10-K · filed 2021-02-11 | |
| 2020-09-30 | $221.54M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $239.19M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $223.69M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $216.08M 10-K · filed 2020-02-13 | |
| 2019-09-30 | $232.28M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $255.33M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $213.32M 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $184.84M 10-K · filed 2019-02-15 | |
| 2018-09-30 | $212.50M 10-Q · filed 2018-10-23 | |
| 2018-06-30 | $251.66M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $215.56M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $234.77M 10-K · filed 2018-02-16 | |
| 2017-09-30 | $251.36M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $281.45M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $278.08M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $282.36M 10-K · filed 2017-02-17 | |
| 2016-09-30 | $253.08M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $338.97M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $255.32M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $327.94M 10-K · filed 2016-02-25 | |
| 2015-09-30 | $356.18M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $342.34M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $334.21M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $323.50M 10-K · filed 2015-02-24 | |
| 2014-09-30 | $298.88M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $296.06M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $225.76M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $107.37M 10-KT · filed 2014-02-27 | |
| 2013-09-30 | $86.90M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $85.72M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $80.39M 10-K · filed 2013-05-23 | |
| 2012-09-30 | $30.99M 10-Q · filed 2013-01-31 | $29.29M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $58.75M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $60.83M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |